Note to our followers: Our nearly 13-year run of daily publication of new content on HealthNewsReview.org came to a close at the end of 2018. Publisher Gary Schwitzer and other contributors may post new articles periodically. But all of the 6,000+ articles we have published contain lessons to help you improve your critical thinking about health care interventions. And those will be still be alive on the site for a couple of years.

Tag: Duchenne’s muscular dystrophy

6/25/2018

‘Home run’ gene therapy for Duchenne muscular dystrophy: Investor-oriented coverage pitches promise but …

6/9/2017

5-Star Friday: Emotions vs. evidence

3 9/28/2016

What some stories missed about the muscular dystrophy drug approval: Pharma’s close ties to vocal patient advocacy groups

3 6/22/2016

What’s at stake in the FDA’s decision on eteplirsen, an experimental muscular dystrophy drug